For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
15
views
11
references
 Top references
cited by
3
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      387
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma – A case report and review of the literature

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Renal involvement in Hodgkin lymphoma (HL) is rare, although extralymphatic disease is usually found. Acute kidney injury is a recognized presentation of non-Hodgkin lymphoma, with bilateral kidney involvement, promptly requiring specific treatment. Regarding to HL, this manifestation is extremely rare and lacks pathologic description and management experiences. Herein, we describe a case of HL with atypical presentation as well as its management, current evaluation by PET-scan and histologic findings. This case report highlights clinical presentation and a successful experience on managing these cases. Moreover, it is important to drive biologic insights for understanding of kidney infiltration mechanism in HL.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Hodgkin Lymphoma: Diagnosis and Treatment.

          Stephen Ansell (2015)
          Hodgkin lymphoma is a rare B-cell malignant neoplasm affecting approximately 9000 new patients annually. This disease represents approximately 11% of all lymphomas seen in the United States and comprises 2 discrete disease entities--classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Within the subcategorization of classical Hodgkin lymphoma are defined subgroups: nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte-rich Hodgkin lymphoma. Staging of this disease is essential for the choice of optimal therapy. Prognostic models to identify patients at high or low risk for recurrence have been developed, and these models, along with positron emission tomography, are used to provide optimal therapy. The initial treatment for patients with Hodgkin lymphoma is based on the histologic characteristics of the disease, the stage at presentation, and the presence or absence of prognostic factors associated with poor outcome. Patients with early-stage Hodgkin lymphoma commonly receive combined-modality therapies that include abbreviated courses of chemotherapy followed by involved-field radiation treatment. In contrast, patients with advanced-stage Hodgkin lymphoma commonly receive a more prolonged course of combination chemotherapy, with radiation therapy used only in selected cases. For patients with relapse or refractory disease, salvage chemotherapy followed by high-dose treatment and an autologous stem cell transplant is the standard of care. For patients who are ineligible for this therapy or those in whom high-dose therapy and autologous stem cell transplant have failed, treatment with brentuximab vedotin is a standard approach. Additional options include palliative chemotherapy, immune checkpoint inhibitors, nonmyeloablative allogeneic stem cell transplant, or participation in a clinical trial testing novel agents.
          Article 0 comments Cited 54 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Renal lesions associated with malignant lymphomas.

            John R. Richmond, Robert S. Sherman, Henry D. Diamond … (1962)
            Article 0 comments Cited 32 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical review: Specific aspects of acute renal failure in cancer patients

              Michael Darmon, Magali Ciroldi, Guillaume Thiery … (2006)
              Acute renal failure (ARF) in cancer patients is a dreadful complication that causes substantial morbidity and mortality. Moreover, ARF may preclude optimal cancer treatment by requiring a decrease in chemotherapy dosage or by contraindicating potentially curative treatment. The pathways leading to ARF in cancer patients are common to the development of ARF in other conditions. However, ARF may also develop due to etiologies arising from cancer treatment, such as nephrotoxic chemotherapy agents or the disease itself, including post-renal obstruction, compression or infiltration, and metabolic or immunological mechanisms. This article reviews specific renal disease in cancer patients, providing a comprehensive overview of the causes of ARF in this setting, such as treatment toxicity, acute renal failure in the setting of myeloma or bone marrow transplantation.
              Article 0 comments Cited 25 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                Valeria Buccheri
                Journal
                Journal ID (nlm-ta): Leuk Res Rep
                Journal ID (iso-abbrev): Leuk Res Rep
                Title: Leukemia Research Reports
                Publisher: Elsevier
                ISSN (Electronic): 2213-0489
                Publication date PMC-release: 29 August 2018
                Publication date Collection: 2018
                Publication date (Electronic): 29 August 2018
                Volume: 10
                Pages: 41-43
                Affiliations
                [a ]Discipline of Hematology, Faculty of Medicine of University of São Paulo (FMUSP), Av. Dr. Arnaldo, 251, 1° andar, ZIP: 01246-000, Brazil
                [b ]Discipline of Nephrology, Faculty of Medicine of University of São Paulo (FMUSP), Brazil
                [c ]Radiology and Oncology Department, Faculty of Medicine of University of São Paulo (FMUSP), Brazil
                [d ]Pathology Department, Faculty of Medicine of University of São Paulo (FMUSP), Brazil
                Author notes
                [* ]Corresponding author. valeria.buccheri@ 123456hc.fm.usp.br
                Article
                Publisher ID: S2213-0489(18)30014-1
                DOI: 10.1016/j.lrr.2018.07.003
                PMC ID: 6138943
                PubMed ID: 30225192
                SO-VID: b5f32611-b315-46cc-8f16-f1431a0482d6
                Copyright © © 2018 The Authors. Published by Elsevier Ltd.
                License:

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Date received : 12 February 2018
                Date revision received : 11 July 2018
                Date accepted : 25 July 2018
                Categories
                Subject: Article

                Keywords: hodgkin lymphoma,renal involvement,acute kidney injury,chemotherapy
                Data availability:
                Keywords: hodgkin lymphoma, renal involvement, acute kidney injury, chemotherapy

                Comments

                Comment on this article

                scite_

                Similar content387

                See all similar

                Cited by3

                See all cited by

                Most referenced authors92

                See all reference authors